Scholarlink

Abstract <p>This work investigates the impact of rifampicin-resistance mutations on the synthesis of secondary metabolites with antioxidant, DNA-protective, and SOS-inhibitory properties in two probiotic strains <i>Bacillus amyloliquefaciens</i> B-1895 and <i>B. subtilis</i> KATMIRA1933. Rifampicin-resistant (RifR) mutants of these strains demonstrated significantly enhanced biological activities compared to their wild-type counterparts. Antioxidant activity increased by 30.39% in <i>B. subtilis</i> KATMIRA1933 and 24.55% in <i>B. amyloliquefaciens</i> B-1895 mutants, while DNA-protective activity rose by 6.67 and 6.27%, respectively. SOS-inhibitory activity also improved, notably by 17.27% in <i>B. subtilis</i> mutants and 3.12% in <i>B. amyloliquefaciens</i>. Genomic analysis revealed the presence of genes responsible for the synthesis of non-ribosomal peptides and polyketides, which are likely contributors to these enhanced activities. These findings suggest that RifR mutants can serve as effective producers of metabolites with antioxidant, DNA-protective, and SOS-inhibitory properties, offering potential applications in agriculture and pharmacology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Influence of Rifampicin-Resistance Mutations on the Synthesis of Antioxidant, DNA-Protective, and SOS-Inhibitory Metabolites

  • 期刊论文

  • 发表日期：

    2025年4月18日

查看全文
  • V. N. Statsenko,
  • E. V. Prazdnova,
  • M. P. Kulikov

摘要

Abstract

This work investigates the impact of rifampicin-resistance mutations on the synthesis of secondary metabolites with antioxidant, DNA-protective, and SOS-inhibitory properties in two probiotic strains Bacillus amyloliquefaciens B-1895 and B. subtilis KATMIRA1933. Rifampicin-resistant (RifR) mutants of these strains demonstrated significantly enhanced biological activities compared to their wild-type counterparts. Antioxidant activity increased by 30.39% in B. subtilis KATMIRA1933 and 24.55% in B. amyloliquefaciens B-1895 mutants, while DNA-protective activity rose by 6.67 and 6.27%, respectively. SOS-inhibitory activity also improved, notably by 17.27% in B. subtilis mutants and 3.12% in B. amyloliquefaciens. Genomic analysis revealed the presence of genes responsible for the synthesis of non-ribosomal peptides and polyketides, which are likely contributors to these enhanced activities. These findings suggest that RifR mutants can serve as effective producers of metabolites with antioxidant, DNA-protective, and SOS-inhibitory properties, offering potential applications in agriculture and pharmacology.